Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Marathon Oil Co. stock logo
MRO
Marathon Oil
$27.77
+0.1%
$26.72
$21.63
$30.06
$15.87B2.229.71 million shs5.87 million shs
Northern Trust Co. stock logo
NTRS
Northern Trust
$83.38
-0.1%
$83.67
$62.44
$89.25
$17.06B1.131.52 million shs1.28 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.40
+0.6%
$26.96
$25.20
$40.37
$143.83B0.6142.02 million shs46.53 million shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.00%+0.98%-2.01%+19.75%+14.94%
Northern Trust Co. stock logo
NTRS
Northern Trust
0.00%+2.37%-6.23%+2.56%+6.68%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-2.31%-8.47%-7.54%-34.69%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Marathon Oil Co. stock logo
MRO
Marathon Oil
4.7838 of 5 stars
3.45.02.50.03.12.52.5
Northern Trust Co. stock logo
NTRS
Northern Trust
3.1027 of 5 stars
1.15.03.30.03.32.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9728 of 5 stars
3.23.04.24.83.01.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Marathon Oil Co. stock logo
MRO
Marathon Oil
2.81
Moderate Buy$32.6617.60% Upside
Northern Trust Co. stock logo
NTRS
Northern Trust
2.10
Hold$84.921.84% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3343.04% Upside

Current Analyst Ratings

Latest NTRS, PFE, and MRO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$32.00
4/22/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingPositive ➝ Positive$33.00
4/19/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $34.00
4/18/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$101.00 ➝ $103.00
4/17/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$93.00 ➝ $101.00
4/15/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$26.00 ➝ $27.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/11/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$35.00 ➝ $45.00
4/10/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$35.00
4/5/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$35.00 ➝ $36.00
4/4/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$86.00 ➝ $87.00
(Data available from 4/29/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Marathon Oil Co. stock logo
MRO
Marathon Oil
$6.70B2.37$6.49 per share4.28$19.15 per share1.45
Northern Trust Co. stock logo
NTRS
Northern Trust
$12.12B1.41$9.61 per share8.68$54.83 per share1.52
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.46$2.98 per share8.53$15.81 per share1.61

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Marathon Oil Co. stock logo
MRO
Marathon Oil
$1.55B$2.5610.858.54N/A23.20%14.09%7.99%5/1/2024 (Confirmed)
Northern Trust Co. stock logo
NTRS
Northern Trust
$1.11B$4.5318.4111.781.207.59%12.57%0.91%7/17/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3670.569.171.143.62%10.88%4.91%5/1/2024 (Confirmed)

Latest NTRS, PFE, and MRO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Marathon Oil Co. stock logo
MRO
Marathon Oil
$0.55N/A-$0.55N/AN/AN/A  
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
2/22/2024Q4 2023
Marathon Oil Co. stock logo
MRO
Marathon Oil
$0.62$0.69+$0.07$0.70$1.66 billion$1.69 billion      
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Marathon Oil Co. stock logo
MRO
Marathon Oil
$0.441.58%+72.41%17.19%3 Years
Northern Trust Co. stock logo
NTRS
Northern Trust
$3.003.60%+2.33%66.23%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.61%+2.57%466.67%15 Years

Latest NTRS, PFE, and MRO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Quarterly$0.753.69%6/7/20246/7/20247/1/2024
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
4/24/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
quarterly$0.111.6%5/14/20245/15/20246/10/2024
1/31/2024
Marathon Oil Co. stock logo
MRO
Marathon Oil
quarterly$0.111.93%2/20/20242/21/20243/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.30
0.40
0.35
Northern Trust Co. stock logo
NTRS
Northern Trust
0.61
0.71
0.71
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Marathon Oil Co. stock logo
MRO
Marathon Oil
77.24%
Northern Trust Co. stock logo
NTRS
Northern Trust
83.19%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.35%
Northern Trust Co. stock logo
NTRS
Northern Trust
0.64%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Marathon Oil Co. stock logo
MRO
Marathon Oil
1,681571.48 million569.48 millionOptionable
Northern Trust Co. stock logo
NTRS
Northern Trust
23,100204.59 million203.28 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

NTRS, PFE, and MRO Headlines

SourceHeadline
Raymond James & Associates Raises Position in Pfizer Inc. (NYSE:PFE)Raymond James & Associates Raises Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 28 at 10:53 PM
The Motley Fool: Pfizer offers a pfat 6.4% dividendThe Motley Fool: Pfizer offers a pfat 6.4% dividend
dallasnews.com - April 28 at 2:54 PM
5 Of The Highest Yielding Blue Chip Stocks To Buy Now5 Of The Highest Yielding Blue Chip Stocks To Buy Now
247wallst.com - April 28 at 7:45 AM
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
fool.com - April 28 at 5:50 AM
Pfizer (NYSE:PFE) Stock Price Up 0.3%Pfizer (NYSE:PFE) Stock Price Up 0.3%
americanbankingnews.com - April 28 at 3:18 AM
Pfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Hold" from AnalystsPfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Hold" from Analysts
americanbankingnews.com - April 28 at 2:28 AM
Pfizer (NYSE:PFE) Sets New 12-Month Low at $25.20Pfizer (NYSE:PFE) Sets New 12-Month Low at $25.20
americanbankingnews.com - April 28 at 1:52 AM
Pfizer Inc. (PFE)Pfizer Inc. (PFE)
finance.yahoo.com - April 27 at 11:37 PM
Pfizer gets FDA approval for hemophilia B gene therapy BeqvezPfizer gets FDA approval for hemophilia B gene therapy Beqvez
msn.com - April 27 at 11:37 PM
PFG Investments LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)PFG Investments LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 27 at 10:17 PM
3 Dividend Stocks to Buy and Hold for the Next Decade3 Dividend Stocks to Buy and Hold for the Next Decade
fool.com - April 27 at 7:15 AM
7 Dividend Stocks to Buy Now for Steady Returns in Any Market7 Dividend Stocks to Buy Now for Steady Returns in Any Market
investorplace.com - April 27 at 6:00 AM
Pfizer’s First Gene Therapy Gets Approval for Clotting DisorderPfizer’s First Gene Therapy Gets Approval for Clotting Disorder
bloomberg.com - April 26 at 10:34 PM
Pfizer (NYSE:PFE) Notches Up on New FDA ApprovalPfizer (NYSE:PFE) Notches Up on New FDA Approval
msn.com - April 26 at 10:34 PM
Stanley Laman Group Ltd. Buys 44,722 Shares of Pfizer Inc. (NYSE:PFE)Stanley Laman Group Ltd. Buys 44,722 Shares of Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 26 at 9:14 PM
What Factors Will Drive Pfizers Q1 Performance?What Factors Will Drive Pfizer's Q1 Performance?
forbes.com - April 26 at 5:34 PM
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, UniqurePfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
finance.yahoo.com - April 26 at 5:34 PM
FDA Green Lights Pfizers Gene Therapy For Rare Bleeding Disorder HemophiliaFDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
finance.yahoo.com - April 26 at 5:34 PM
Pfizer (NYSE:PFE) Sets New 52-Week Low at $25.20Pfizer (NYSE:PFE) Sets New 52-Week Low at $25.20
marketbeat.com - April 26 at 2:35 PM
GSK sues Pfizer and BioNTech over mRNA billionsGSK sues Pfizer and BioNTech over mRNA billions
thepharmaletter.com - April 26 at 12:33 PM
Pfizer Gains as Gene Therapy Wins FDA NodPfizer Gains as Gene Therapy Wins FDA Nod
baystreet.ca - April 26 at 12:33 PM
FDA approves Pfizer’s gene therapy Beqvez for adults with hemophilia BFDA approves Pfizer’s gene therapy Beqvez for adults with hemophilia B
thepharmaletter.com - April 26 at 12:33 PM
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key MetricsGear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
zacks.com - April 26 at 10:21 AM
Pfizer Receives FDA Approval for Bleeding Disorder TreatmentPfizer Receives FDA Approval for Bleeding Disorder Treatment
barrons.com - April 26 at 9:35 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Marathon Oil logo

Marathon Oil

NYSE:MRO
Marathon Oil Corporation, an independent exploration and production company, engages in exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas in the United States and internationally. The company also produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol. In addition, it owns and operates Sugarloaf gathering system, a natural gas pipeline. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in December 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.
Northern Trust logo

Northern Trust

NASDAQ:NTRS
Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; muti-asset and alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.